Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis

OBJECTIVES: Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective salvage therapies are urgently needed. MATERIALS AND METHODS: We aimed to define efficacy and safety of checkpoint in...

Descripción completa

Detalles Bibliográficos
Autores principales: Stratmann, Jan A., Timalsina, Radha, Atmaca, Akin, Rosery, Vivian, Frost, Nikolaj, Alt, Jürgen, Waller, Cornelius F., Reinmuth, Niels, Rohde, Gernot, Saalfeld, Felix C., von Rose, Aaron Becker, Acker, Fabian, Aspacher, Lukas, Möller, Miriam, Sebastian, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168937/
https://www.ncbi.nlm.nih.gov/pubmed/35677321
http://dx.doi.org/10.1177/17588359221097191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168937/
https://www.ncbi.nlm.nih.gov/pubmed/35677321
http://dx.doi.org/10.1177/17588359221097191

Ejemplares similares